Single-center experience evaluating and initiating people with HIV on long-acting cabotegravir/rilpivirine.

Lucas A Hill, Kari K Abulhosn, Jeffrey F Yin,Laura P Bamford

AIDS (London, England)（2023）

引用 4|浏览8

暂无评分

摘要

Despite novel challenges over half of our cohort initiated LAI CAB/RPV. Evaluating for potential non-nucleoside reverse transcriptase inhibitor resistance is an important part of the workup for LAI CAB/RPV and proviral DNA resistance testing can be an additional tool to identify potential resistance.

查看译文

关键词

hiv,cabotegravir/rilpivirine,cabotegravir/rilpivirine,single-center,long-acting

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要